Inactive Instrument

Magellan Health, Inc.

MGLN

US5590792074

Magellan Health : to Present at Barclays Select Series Biosimilars Symposium

October 02, 2015 at 10:16 am EDT

Magellan Health, Inc. (NASDAQ: MGLN) announced today that Mostafa Kamal, chief executive officer of Magellan Rx Management, the company’s pharmacy benefit management division, will participate in a panel discussion at the Barclays Select Series Biosimilars Symposium in New York on Wednesday, October 7, 2015 from 8:45-10:15 a.m. Eastern. The panelists will discuss the topic “Determining Access, Driving Acceptance: Biosimilars’ Journey through the Pharmaceutical Supply Chain.”

About Magellan Health: Headquartered in Scottsdale, Ariz., Magellan Health, Inc. is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan develops innovative solutions that combine advanced analytics, agile technology and clinical excellence to drive better decision making, positively impact health outcomes and optimize the cost of care for the members it serves – all within a customer-first culture. Magellan’s customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies, third-party administrators, consultants and brokers. For more information, visit MagellanHealth.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20151002005488/en/

Latest news about Magellan Health, Inc.

Magellan Health, Inc. Announces Market Leadership Appointments	23-09-15	CI
Magellan Health, Inc. Launches iMclusion - a New DEI Solution for Employers	23-08-24	CI
Autism Analytica Collaborates with Magellan Health to Identify Autism, Predict Services Needed, and Monitor Patient Progress	23-04-24	CI
Evolent Health, Inc. completed the acquisition of Magellan Specialty Health, Inc. and National Imaging Associates, Inc. from Magellan Health, Inc. and Magellan Healthcare, Inc. for approximately $800 million.	23-01-19	CI
Prime Therapeutics LLC completed the acquisition of Magellan Rx Management, Inc. from Magellan Health, Inc.	22-12-04	CI
Evolent Health, Inc. entered into a definitive agreement to acquire Magellan Specialty Health, Inc. /National Imaging Associates, Inc. from Magellan Health, Inc. and Magellan Healthcare Inc. for approximately $800 million.	22-11-16	CI
Magellan Health Opens 24-hour Crisis Line for Individuals Impacted by Hurricane Ian	22-09-29	CI
Magellan Health, Inc. Appoints Tom Britt as Chief Information Officer	22-08-08	CI
Magellan Health, Inc. Appoints Derrick Duke as Chief Executive Officer	22-07-07	CI
Prime Therapeutics LLC entered into a definitive agreement to acquire Magellan Rx Management, Inc. from Magellan Health, Inc. for approximately $1.35 billion.	22-05-04	CI
Magellan Health Announces Total Wellbeing Solution for Employers	22-02-08	CI
Magellan Health, Inc.(NasdaqGS:MGLN) dropped from S&P TMI Index	22-01-05	CI
Magellan Health, Inc.(NasdaqGS:MGLN) dropped from S&P 1000	22-01-05	CI
Magellan Health, Inc.(NasdaqGS:MGLN) dropped from S&P Global BMI Index	22-01-05	CI
Magellan Health, Inc.(NasdaqGS:MGLN) dropped from S&P 600 Health Care	22-01-05	CI
Magellan Health, Inc.(NasdaqGS:MGLN) dropped from S&P Composite 1500	22-01-05	CI
Magellan Health, Inc.(NasdaqGS:MGLN) dropped from S&P 600	22-01-05	CI
Magellan Health, Inc.(NasdaqGS:MGLN) dropped from S&P Health Care Services Select Industry Index	22-01-05	CI
Magellan Health, Inc.(NasdaqGS:MGLN) dropped from NASDAQ Composite Index	22-01-04	CI
Centene Corporation completed the acquisition of Magellan Health, Inc. from a group of shareholders.	22-01-03	CI
ITeos Therapeutics to Join S&P SmallCap 600	22-01-03	MT
Centene's Proposed Acquisition of Magellan Health Secures California Regulator's Nod With Conditions	21-12-30	MT
Magellan Health Unit Launches Emotional Wellbeing Digital Service	21-12-28	MT
Centene Reaffirms 2021 Financial Guidance, Sees Strong 2022	21-12-10	MT
Magellan Health Announces Two New Appointments to Magellan Health Studio Advisory Council	21-11-12	CI

Chart Magellan Health, Inc.

Duration

Period

More charts

Company Profile

Magellan Health, Inc. is engaged in the healthcare management business. The Company provides managed care and pharmacy solutions for healthcare. The Company's segments include Healthcare, Pharmacy Management and Corporate. Its Healthcare includes carve-out management services for behavioral health, employee assistance plans (EAP) and other areas of specialty healthcare including diagnostic imaging, musculoskeletal management, cardiac and physical medicine. Its Pharmacy Management segment consists of products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Its Corporate segment consists of amounts not allocated to the Healthcare and Pharmacy Management segments. The Company provides services to health plans and other managed care organizations (MCOs), employers, labor unions, various military and governmental agencies and third party administrators (TPAs).

Sector

Managed Healthcare

More about the company

Sector Other Managed Healthcare

	1st Jan change	Capi.
ELEVANCE HEALTH, INC.	+14.15%	125B
CIGNA	+18.28%	101B
CENTENE CORPORATION	-0.20%	40.48B
HUMANA INC.	-32.71%	37.53B
MOLINA HEALTHCARE, INC.	-4.93%	20.64B
PROGYNY, INC.	-12.61%	3.12B
ALIGNMENT HEALTHCARE, INC.	-39.90%	975M
CLOVER HEALTH INVESTMENTS, CORP.	-28.97%	332M

Other Managed Healthcare